The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNeometals Regulatory News (NMT)

Share Price Information for Neometals (NMT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.00
Bid: 5.50
Ask: 6.50
Change: 0.00 (0.00%)
Spread: 1.00 (18.182%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 6.00
NMT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Lithium Chemicals Update

21 Mar 2024 07:00

RNS Number : 7574H
Neometals Ltd
21 March 2024
 

21 March 2024

Neometals Ltd

("Neometals" or "the Company")

Lithium Chemicals Update

Highlights:

· Reed Advanced Materials (Neometals 70%, Mineral Resources 30%) and Lifthium Energy have ceased discussions in relation to updated arrangements for the evaluation of a lithium refinery in Portugal; and

· Reed Advanced Materials will sole fund the final stage of the pilot test work program for its patented ELi? process and will pursue a low-capital, low-risk technology licensing business model.

Sustainable process technology developer, Neometals Ltd (ASX: NMT & AIM: NMT) ("Neometals" or "the Company") advises that its joint venture company, Reed Advanced Materials Pty Ltd ("RAM") (70% NMT, 30% Mineral Resources Ltd) has ceased discussions with Lifthium Energy SA ("Lifthium") in relation to updated arrangements for the further evaluation of a lithium refinery to produce lithium chemicals in Estarreja, Portugal. RAM will proceed to complete the final stage of pilot test work and intends to commercialise its proprietary ELi? process which comprises an extensive patented technology package through a licensing business model.

RAM has been co-funding evaluation activities with Bondalti Chemicals SA ("Bondalti") and negotiating a new co-operation framework with Bondalti's sister company, Lifthium.[i] RAM and Bondalti completed an Engineering Cost Study ("ECS") to AACE Class 3 standard for a 25,000tpa lithium hydroxide monohydrate merchant refinery in Portugal and have been advancing a phased pilot scale test work program in Canada ("Pilot").

The ECS confirmed the technical feasibility of the process to purify and convert lithium chloride to lithium hydroxide with potential lowest-quartile operating costs and capital cost intensity. Additionally, the first stage of the Pilot successfully purified lithium chloride from an existing South American operation to the specification required for conversion by electrolysis using ELi?[ii]. Despite the compelling operating / capital cost metrics and successful purification Pilot activities, RAM and Lifthium have been unable to agree terms for further joint evaluation activities and licensing arrangements. 

RAM is fully funded to complete the final stage of Pilot test work and will continue to test third-party brines for potential partners under a low-capex, low-risk technology licensing business model to generate future royalty income.

Neometals Managing Director Chris Reed said:

"Neometals appreciates the collaboration with Bondalti in advancing the commercialisation of our ELi? process. We are committed to the commercialisation of ELi? which we see as the future of sustainable low-cost lithium production from brines to meet the demands of the transport electrification and energy storage thematic. In light of the current price cycle, we will pivot towards a more conservative business model for commercialisation."

Authorised on behalf of Neometals by Christopher Reed, Managing Director.

ENDS

For more information, please contact:

 

Neometals Ltd

Chris Reed, Managing Director & Chief Executive Officer

 +61 8 9322 1182

Jeremy McManus, General Manager - IP & IR

 +61 8 9322 1182

 

Cavendish Capital Markets Ltd - NOMAD & Joint Broker

 

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

 

About Neometals

Neometals is commercialising a portfolio of sustainable processing solutions that recycle and recover critical materials from high value waste streams. The Company collaborates with partners and customers to facilitate circular supply chains and reduce the environmental burden of traditional mining in the global transition to a sustainable economy. Neometals' three core business units are exploiting the technologies under principal, joint venture and licensing business models:

· Lithium-ion Battery ("LiB") Recycling (50% technology) - Commercialisation via Primobius GmbH JV (NMT 50% equity). All plants built by Primobius' co-owner (SMS group 50% equity), a 150-year-old German plant builder. Providing recycling service as principal in Germany and commenced plant supply and licensing activities as technology partner to Mercedes-Benz. Primobius targeting first commercial, fully integrated, 21,000tpa plant offer to Canadian company Stelco in the JunQ 2025;

· Lithium Chemicals (70% technology) - Commercialising patented ELi? electrolysis process, co-owned 30% by Mineral Resources Ltd, to produce battery quality lithium hydroxide from brine and/or hard-rock feedstocks at lowest quartile operating costs. Pilot scale test work and Engineering Cost Study update in progress. Commercialisation strategy is through technology licensing model; and

· Vanadium Recovery (100% technology) - aiming to enable sustainable production of high-purity vanadium pentoxide from processing of steelmaking by-product ("Slag") at lowest-quartile operating cost. Targeting partnerships with steel makers and participants in the vanadium chemical value chain under a low risk / low capex technology licensing business model.

For further information visit www.neometals.com.au

 


[i] For full details refer to Neometals ASX announcement titled "Lithium Chemicals Co-operation Update" dated 3 October 2023.

[ii] For full details refer to Neometals ASX announcements titled "Portugal Lithium Refinery Study Confirms Step-change Opex of ELi? Technology" dated 26 April 2023 and "Successful Eli Purification Pilot Trial" dated 10 November 2023.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFZGZFVMGGDZG
Date   Source Headline
24th Apr 20247:01 amRNSQuarterly Cashflow Report
24th Apr 20247:00 amRNSQuarterly Activities Report
18th Apr 202410:24 amRNSChange in Substantial Holding
21st Mar 20247:00 amRNSLithium Chemicals Update
15th Mar 202412:26 pmRNSChange in Substantial Holding
14th Mar 20248:57 amRNSCorporate Presentation
14th Mar 20247:56 amRNSHalf-year Report
4th Mar 20249:35 amRNSIssue of Shares
13th Feb 20247:03 amRNSSpargos Exploration Update
2nd Feb 20247:00 amRNSCorporate Presentation
25th Jan 20247:07 amRNSQuarterly Cashflow Report
25th Jan 20247:06 amRNSQuarterly Activities Report
23rd Jan 20245:17 pmRNSDirector/PDMR Shareholding
10th Jan 20247:00 amRNSMercedes-Benz Refinery Purchase Order
22nd Dec 20237:00 amRNSPrimobius Commercial Update
19th Dec 20237:34 amRNSPrimobius Achieves 85% Carbon Emissions Reduction
18th Dec 20231:45 pmRNSDirector & PDMR Participation in Entitlement Offer
13th Dec 20237:00 amRNSResults of Non-Renounceable Entitlement Offer
6th Dec 202312:24 pmRNSDirector/PDMR Shareholding
29th Nov 20237:39 amRNSEntitlement Offer Opens
27th Nov 20231:15 pmRNSDirector/PDMR Dealings
24th Nov 202312:18 pmRNSChairman's AGM 2023 Address
24th Nov 202312:16 pmRNSResults of Annual General Meeting
23rd Nov 20237:00 amRNSNeometals Closes A$9.0 Million Placement
20th Nov 20234:45 pmRNSProposed Equity Raise to Advance Primobius
20th Nov 202311:56 amRNSChange of Nominated Adviser
20th Nov 20239:20 amRNSAnnual General Meeting - Withdrawal of Resolution
13th Nov 20237:38 amRNSNeometals Discovers Spodumene-bearing Pegmatite
10th Nov 20237:00 amRNSSuccessful ELi Purification Pilot Trial
8th Nov 20237:00 amRNSOutstanding Nickel Sulphate Purity for Primobius
30th Oct 20237:02 amRNSQuarterly cash flow report
30th Oct 20237:01 amRNSQuarterly Activities Report
30th Oct 20237:00 amRNSVanadium Recovery Strategy Update
23rd Oct 20237:28 amRNSNotice of Annual General Meeting
18th Oct 20231:57 pmRNSASX Aware Query
6th Oct 20237:02 amRNSBattery Recycling Expert to Lead NMT Recycling
4th Oct 20237:11 amRNSOutstanding Lithium Recovery Results for Primobius
3rd Oct 20238:33 amRNSLithium Chemicals Co-operation Update
3rd Oct 20237:00 amRNSRetail Investor Conference Participation
2nd Oct 20238:42 amRNSVanadium Recovery Project Update
2nd Oct 20238:33 amRNSBarrambie Offtake Update
29th Sep 20238:29 amRNSAnnual Financial Report
22nd Sep 20239:10 amRNSExtension of Managing Director's Contract
21st Sep 20237:00 amRNSGrant of Battery Recycling Patent
18th Sep 20239:26 amRNSChange in Substantial Holding
13th Sep 202310:17 amRNSNotice of Annual General Meeting
11th Sep 202310:52 amRNSDirector / PDMR Dealings
22nd Aug 20238:14 amRNSMercedes Battery Recycling Plant Purchase Order
1st Aug 20237:35 amRNSBattery Recycling 'Hub' Engineering Cost Study
28th Jul 20237:46 amRNSQuarterly cash flow report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.